

Related Companies | [] | ||||||||
Related Funds | [] | ||||||||
English | |||||||||
oda_WinningATenderAbstract| |
| ||||||||
oda_UpdateAnnouncementFlag| |
| Evet (Yes) | |||||||
oda_CorrectionAnnouncementFlag| |
| Hayır (No) | |||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject| |
| 27/03/2026 | |||||||
oda_DelayedAnnouncementFlag| |
| Hayır (No) | |||||||
oda_AnnouncementContentSection| |
| ||||||||
oda_SubjectOfTender| |
| MANUEL/TAM OTOMATİK İNFÜZYON KEMOTERAPİSİ HİZMET ALIMI | |||||||
oda_PartyOpenedTender| |
| ŞAHİNBEY ARAŞTIRMA VE UYGULAMA HASTANESİ BAŞHEKİMLİĞİ | |||||||
oda_BoardDecisionOnBidForTender| |
| - | |||||||
oda_OtherPartiesIfParticipatedInTheTenderAsAGroup| |
| - | |||||||
oda_ShareOfTheCompanyIfParticipatedInTheTenderAsAGroup| |
| - | |||||||
oda_DateOfTenderBid| |
| 26/03/2026 | |||||||
oda_EndingUpDateOfTheTender| |
| 27/03/2026 | |||||||
oda_TenderResult| |
| The tender has been awarded to our Company. | |||||||
oda_TenderValue| |
| 141.051.834,15 | |||||||
oda_ShareOfCompanyInTenderValue| |
| - | |||||||
oda_RatioOfTenderValueCorporateShareAmountToGrossSalesRevenueOnPubliclyDisclosedTheLatestFinancialStatementOfCompany| |
| - | |||||||
oda_ExplanationSection| |
| ||||||||
oda_ExplanationTextBlock| | In our Public Disclosure dated 27/03/2026, it was stated that: "Our Company participated in the tender for the ‘36-Month Manual/Fully Automatic Infusion Chemotherapy Service Procurement' held on 26/03/2026 by the Chief Physician's Office of Gaziantep University Şahinbey Research and Application Hospital. According to the data announced on the Electronic Public Procurement Platform (EKAP), among the three bidders participating in the tender, our Company's bid amounting to TRY 141,051,834.15 was the most economically advantageous offer. The tender process was ongoing, and the finalized tender decision was awaited to be notified to our Company." Subsequently, the finalized tender decision dated 30/03/2026 and numbered 1 has been notified to our Company via the Electronic Public Procurement Platform (EKAP). Respectfully announced to the public. The English translation of this disclosure is provided in the attachment. In case of any discrepancy between the Turkish and English versions of the disclosure texts, the Turkish version shall prevail. | ||||||||
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.